HFA-ICOS Baseline Cardio-Oncology Risk Assessment for HER2-Targeted Therapies

Código: 10643 · hfa_icos_baseline_cardio_oncology_risk_assessment_her2_targeted_therapies

Stratifies cardiotoxicity risk in cancer patients scheduled to receive HER2-targeted therapies.